Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Vector
Vector® TrueVIEW™ Autofluorescence Quenching Kit
Product Details | |
---|---|
Product Type | Kit |
Properties | |
Application Set | Compound Screening |
Crossreactivity | All |
Kit Contains |
Vector® TrueVIEW™ Reagent A, 5 ml |
Other Product Data |
The Vector® TrueVIEW™ Autofluorescence Quenching Kit provides a novel way to diminish unwanted autofluorescence from non-lipofuscin sources and dramatically improve signal-to-noise ratio. The quenching action of the kit reagents provides a clear, unambiguous, "true view" localization of the target antigen. Current methods for reducing autofluorescence primarily include "home brew" concoctions such as sodium borohydride and other ink-based products. These methods are essentially ineffective against aldehyde induced autofluorescence. In contrast, Vector® TrueVIEW™ reagent binds to hydrophilic compounds and effectively quenches endogenous autofluorescence. Tissue autofluorescence often occurs with aldehyde fixation or from inherent native tissue components (collagen, elastin, and red blood cells). The extent and intensity of autofluorescence background frequently makes it difficult or impossible to distinguish specific signals in immunofluorescence applications. Most methods for reduction of tissue autofluorescence act primarily on lipofuscin granules, and are not broadly effective against the most common sources of autofluorescence targeted by Vector® TrueVIEW™ Quencher. |
Declaration | Manufactured by Vector Laboratories |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +20°C |
Long Term Storage | +4°C |
Documents | |
Manual | No |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Autofluorescence quenching kit.
- A novel mouse model of hemangiopericytoma due to loss of Tsc2: H. Du, et al.; Hum. Mol. Genet. 27, 4169 (2018)
- Rab27a regulates human perivascular adipose progenitor cell differentiation: J.M. Boucher, et al.; Cardiovasc. Drugs Ther. 32, 519 (2018)